DocSym
β
Searchsearch
Search
(E26.0) Primary hyperaldosteronism
More details coming soon
111 232 in individuals diagnosis primary hyperaldosteronism confirmed
2 732 deaths with diagnosis primary hyperaldosteronism
3% mortality rate associated with the disease primary hyperaldosteronism
Diagnosis primary hyperaldosteronism is diagnosed Women are 10.07% more likely than Men
50 014
Men receive the diagnosis primary hyperaldosteronism
2 732 (5.5 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
61 218
Women receive the diagnosis primary hyperaldosteronism
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease primary hyperaldosteronism - Men and Women aged 55-59
In Men diagnosis is most often set at age 0-5, 10-89
Less common in men the disease occurs at Age 5-9, 90-95+Less common in women the disease occurs at Age 0-5, 95+
In Women diagnosis is most often set at age 0-1, 5-94
Disease Features primary hyperaldosteronism
Absence or low individual and public risk
Primary hyperaldosteronism - what does this mean
Primary hyperaldosteronism is a condition in which the body produces too much of the hormone aldosterone, causing the body to retain too much sodium and excrete too much potassium. it is caused by an overactive adrenal gland, a tumor on the adrenal gland, or a genetic disorder.
What happens during the disease - primary hyperaldosteronism
Primary hyperaldosteronism is a condition caused by an excessive production of aldosterone due to an abnormality in the adrenal gland, leading to an elevation in the amount of sodium and water retained in the body while simultaneously causing a decrease in the amount of potassium being excreted. this leads to an increase in blood pressure, as well as an increase in the risk of developing other medical conditions, such as heart disease and stroke.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical exam
- Blood tests to measure electrolyte levels and kidney function
- Urine tests to measure electrolyte levels and kidney function
- CT scan or MRI of the adrenal glands
- Adrenal vein sampling
- Renin test
- Genetic testing
- Thyroid function tests
Treatment and Medical Assistance
Main goal of the treatment: To reduce the amount of aldosterone produced by the adrenal glands.
- Prescribing medications to reduce aldosterone production, such as spironolactone or eplerenone.
- Performing a laparoscopic adrenalectomy to remove the affected gland.
- Prescribing medications to reduce blood pressure, such as angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers.
- Recommending lifestyle changes, such as reducing sodium intake and increasing potassium intake.
- Monitoring blood pressure and electrolyte levels.
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Primary hyperaldosteronism - Prevention
Primary hyperaldosteronism can be prevented by maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding cigarettes and excessive alcohol consumption. additionally, controlling blood pressure and monitoring electrolyte levels can help prevent the onset of primary hyperaldosteronism.